摘要
随着人口老龄化问题的加剧,骨质疏松症的高发生率降低了人们的生活质量。越来越多的证据表明,肠道微生物群与骨代谢联系密切,肠道微生物群稳态的破坏会导致宿主的病理生理反应,从而引起骨质疏松。通过研究两者之间的相互作用,或许能为骨质疏松症的预防及相关诊疗提供有价值的帮助。本文就目前肠道微生物与骨质疏松症相关机制和主要治疗的研究现状作一综述。
The high incidence of osteoporosis in the aging population reduces the quality of life.There is growing evidence that the gut microbiota is closely linked to bone metabolism.Gut microbiota disorder will lead to pathophysiological responses in the host,which can cause osteoporosis.The research on the interactions between gut microbiota and osteoporosis may contribute to the management of osteoporosis-related conditions.This paper reviews the advances in the interactions between gut microbiota and osteoporosis and the relevant therapies.
作者
魏晋鹏
常峰
WEI Jinpeng;CHANG Feng(The Fifth Clinical Medical College of Shanxi Medical University,Taiyuan 030012,Shanxi,China;Department of Orthopedics,Shanxi Provincial People’s Hospital,Taiyuan 030012,Shanxi,China)
出处
《微生物学通报》
CAS
CSCD
北大核心
2023年第2期729-741,共13页
Microbiology China
基金
山西省卫生健康委科研计划(2018029,2019019)。
关键词
骨质疏松症
肠道菌群
骨免疫学
骨微生物学
治疗
osteoporosis
gut microbiota
Osteoimmunology
Osteomicrobiology
treatment